The top 10 biopharma M&A deals of 2023
Source: Fierce Pharma While the biopharma industry’s dealmaking totals have yet to eclipse the heady highs of 2019, mergers and acquisitions were back on the menu in a big way in 2023. Last year, the value of the top 10 M&A deals in the biopharma industry came to $115.8 billion, outranking prior sums from 2022, […]
Unlocking Pharma Manufacturing Agility
Source: Economic Times Pharma manufacturing faces unique market and operational challenges. When an attempt is made to manage this high-uncertainty environment with the typical method of monthly production planning, it precipitates a vicious loop of issues. Only a dynamic approach that ensures flexibility on the shop floor can sustainably ensure reliability and high output. In FY […]
Indian pharma industry relies heavily on ingredients made in China
Source: Business Standard The Biden administration embraced a plan from India’s government last year to edge China out of its position as a leader in making ingredients for generic pharmaceuticals sold in the US. But a new report shows that much of those ingredients are likely still coming from China anyway. America’s reliance on China […]
Quality issues Fail to Dent Indian Pharma Exports But Reputation Takes a Hit
Source: News18 Despite multiple complaints raised over the quality of Indian medicines, there is no impact on the export values of pharmaceutical products, said a top pharma official in the Narendra Modi government.“However, it has certainly made a dent in our image,” Udaya Bhaskar, director-general, the Pharmaceuticals Export Promotion Council of India (Pharmexcil), told News18 […]
Teva to divest active pharmaceutical ingredient business
Source: Reuters Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world’s largest generic drugs maker said on Wednesday. The API unit, which brought in revenue of $1.05 billion in 2022, makes pharmaceutical ingredients that are used in both generic and branded medicines, and […]
Panacea Biotech’s Baddi unit gets OAI status from USFDA
Source: CNBCTV18 Panacea Biotech informed the exchanges that the United States Food & Drug Administration (USFDA) has classified the company’s Baddi facility in Himachal Pradesh as an “Official Action Indicated” (OAI). The facility was issued a form-483 by the drug regulator with nine observations in October, which were related to improvements in existing procedures. An […]
Top 10 most anticipated drug launches of 2024
Source: fiercepharma Every year, we tap Evaluate’s annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each presenting potential blockbuster launches. In 2024, however, things are set to play out a little differently. The most anticipated drug comes from a biotech that […]
Top 10 blockbuster drugs that will become off-patent in 2024
Source: Financial Express The discovery and development of innovative medicines play a crucial role in finding treatment and addressing disease burden. The cost of bringing a new drug to market is approximately $5 billion and can take nearly 15 years to get a drug introduced to the market. When a pharmaceutical company develops a new drug to […]
Top 50 Pharmaceutical Companies of the world
Source: Visual Capitalist Globally, big pharma revenues have grown by more than half a trillion dollars since 2012, driven by an aging global population. American drugmakers make up the greatest market share worldwide by far, supported by high prices in a less regulated market. Yet with 190 drug patents expiring in the next decade, many companies face […]
Pharmaways Marks Milestone: Expands Presence to 100 Countries
Written: Abid Ali Khan Pharmaways, the leading pharmaceutical search engine, is celebrating a significant achievement with its expansion into 100 countries worldwide. This milestone solidifies Pharmaways’ position as a go-to resource for stakeholders within the pharmaceutical industry. The platform’s user-friendly interface and advanced search capabilities cater specifically to the needs of professionals, researchers, and decision-makers […]